A patent granted to Swiss giant Roche for a hepatitis C drug has been revoked by an Indian panel. This move is the latest setback for global pharmaceutical firms in the country's (Dollar) 12-billion medicine market. The Intellectual Property Appellate Board overturned the patent awarded by the Indian Patent Office to Hoffmann-La Roche's drug Pegasys used to treat hepatitis C -- a disease that can lead to fatal liver problems. While Roche can still ...Saturday, 3 November 2012
Roche Hepatitis Patent Revoked by India
A patent granted to Swiss giant Roche for a hepatitis C drug has been revoked by an Indian panel. This move is the latest setback for global pharmaceutical firms in the country's (Dollar) 12-billion medicine market. The Intellectual Property Appellate Board overturned the patent awarded by the Indian Patent Office to Hoffmann-La Roche's drug Pegasys used to treat hepatitis C -- a disease that can lead to fatal liver problems. While Roche can still ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment